Antifúngicos <strong>em</strong> infecções oculares: drogas e vias <strong>de</strong> administração141104. Clo<strong>de</strong> AB, Davis JL, Salmon J, Michau TM, Gilger BC. Evaluation ofconcentration of voriconazole in aqueous humor after topical and oraladministration in horses. Am J Vet Res. 2006;67(2):296-301.105. Prakash G, Sharma N, Goel M, Titiyal JS, Vajpayee RB. Evaluation ofintrastromal injection of voriconazole as a therapeutic adjunctive forthe manag<strong>em</strong>ent of <strong>de</strong>ep recalcitrant fungal keratitis. Am JOphthalmol. 2008;146(1):56-9.106. Siatiri H, Daneshgar F, Siatiri N, Kho<strong>da</strong>ban<strong>de</strong> A. The effects of intrastromalvoriconazole injection and topical voriconazole in the treatmentof recalcitrant Fusarium keratitis. Cornea. 2011;30(8):872-5.107. Sharma N, Agarwal P, Sinha R, Titiyal JS, Velpandian T, Vajpayee RB.Evaluation of intrastromal voriconazole injection in recalcitrant <strong>de</strong>epfungal keratitis: case series. Br J Ophthalmol. 2011;95(12):1735-7.108. Giaconi JA, Marangon FB, Miller D, Alfonso EC. Voriconazole andfungal keratitis: a report of two treatment failures. J Ocul PharmacolTher. 2006;22(6):437-9.109. Diek<strong>em</strong>a DJ, Messer SA, Hollis RJ, Jones RN, Pfaller MA. Activitiesof caspofungin, itraconazole, posaconazole, ravuconazole,voriconazole, and amphotericin B against 448 recent clinical isolatesof filamentous fungi. J Clin Microbiol. 2003;41(8):3623-6.110. Johnson LB, Kauffman CA. Voriconazole: a new triazole antifungalagent. Clin Infect Dis. 2003;36(5):630-7.111. Espinel-Ingroff A, Boyle K, Sheehan DJ. In vitro antifungal activitiesof voriconazole and reference agents as <strong>de</strong>termined by NCCLS methods:review of the literature. Mycopathologia. 2001;150(3):101-15.112. Marco F, Pfaller MA, Messer SA, Jones RN. Antifungal activity of anew triazole, voriconazole (UK-109,496), compared with three otherantifungal agents tested against clinical isolates of filamentous fungi.Med Mycol. 1998;36(6):433-6.113. Ullmann AJ, Cornely OA, Burchardt A, Hach<strong>em</strong> R, Kontoyiannis DP,Töpelt K, et al. Pharmacokinetics, safety, and efficacy of posaconazolein patients with persistent febrile neutropenia or refractory invasivefungal infection. Antimicrob Agents Ch<strong>em</strong>other. 2006;50(2):658-66.114. Cuenca-Estrella M, Gomez-Lopez A, Mellado E, Buitrago MJ, MonzonA, Rodriguez-Tu<strong>de</strong>la JL. Head-to-head comparison of the activitiesof currently available antifungal agents against 3,378 Spanish clinicalisolates of yeasts and filamentous fungi. Antimicrob AgentsCh<strong>em</strong>other. 2006;50(3):917-21.115. Torres HA, Hach<strong>em</strong> RY, Ch<strong>em</strong>aly RF, Kontoyiannis DP, Raad II.Posaconazole: a broad-spectrum triazole antifungal. Lancet Infect Dis.2005;5(12):775-85.116.Sponsel WE, Graybill JR, Nevarez HL, Dang D. Ocular and syst<strong>em</strong>icposaconazole(SCH-56592) treatment of invasive Fusarium solanikeratitis and endophthalmitis. Br J Ophthalmol. 2002;86(7):829-30.117. Vermes A, Guchelaar HJ, Dankert J. Flucytosine: a review of its pharmacology,clinical indications, pharmacokinetics, toxicity and druginteractions. J Antimicrob Ch<strong>em</strong>other. 2000;46(2):171-9.118. Mabon M. Fungal keratitis. Int Ophthalmol Clin. 1998;38(4):115-23.119. Morris MI, Villmann M. Echinocandins in the manag<strong>em</strong>ent of invasivefungal infections, part 1. Am J Health Syst Pharm.2006;63(18):1693-703. Review.120. Morris MI, Villmann M. Echinocandins in the manag<strong>em</strong>ent of invasivefungal infections, Part 2. Am J Health Syst Pharm.2006;63(19):1813-20. Review.121. Bachmann SP, Van<strong>de</strong>Walle K, Ramage G, Patterson TF, Wickes BL,Graybill JR, López-Ribot JL. In vitro activity of caspofungin againstCandi<strong>da</strong> albicans biofilms. Antimicrob Agents Ch<strong>em</strong>other.2002;46(11):3591-6.122. Wagner C, Graninger W, Presterl E, Joukha<strong>da</strong>r C. The echinocandins:comparison of their pharmacokinetics, pharmacodynamics and clinicalapplications. Pharmacology. 2006;78(4):161-77. Review.123. Goldblum D, Frueh BE, Sarra GM, Katsoulis K, Zimmerli S. Topicalcaspofungin for treatment of keratitis caused by Candi<strong>da</strong> albicans in arabbit mo<strong>de</strong>l. Antimicrob Agents Ch<strong>em</strong>other. 2005;49(4):1359-63.124. Matsumoto Y, Dogru M, Goto E, Fujishima H, Tsubota K. Successfultopical application of a new antifungal agent, micafungin, in the treatmentof refractory fungal corneal ulcers: report of three cases andliterature review. Cornea. 2005;24(6):748-53.125. Matsumoto Y, Murat D, Kojima T, Shimazaki J, Tsubota K. The comparisonof solitary topical micafungin or fluconazole application inthe treatment of Candi<strong>da</strong> fungal keratitis. Br J Ophthalmol.2011;95(10):1406-9.126. Bennett JE, Dismukes WE, Duma RJ, Medoff G, San<strong>de</strong> MA, Gallis H,et al. A comparison of amphotericin B alone and combined withflucytosine in the treatment of cryptoccal meningitis. N Engl J Med.1979;301(3):126-31.127. Arora I, Kulshrestha OP, Upadhaya S. Treatment of fungal cornealulcers with econazole. Indian J Ophthalmol. 1983;31 Suppl:1019-21.128. Sugar AM. Use of amphotericin B with azole antifungal drugs: whatare we doing? Antimicrob Agents Ch<strong>em</strong>other. 1995;39(9):1907-12.129. Cacciapuoti A, Gurnani M, Halpern J, Norris C, Patel R, LoebenbergD. Interaction between posaconazole and amphotericin B in concomitanttreatment against Candi<strong>da</strong> albicans in vivo. Antimicrob AgentsCh<strong>em</strong>other. 2005;49(2):638-42.130. Najvar LK, Cacciapuoti A, Hernan<strong>de</strong>z S, Halpern J, Bocanegra R,Gurnani M, et al. Activity of posaconazole combined with amphotericinB against Aspergillus flavus infection in mice: comparative studiesin two laboratories. Antimicrob Agents Ch<strong>em</strong>other. 2004;48(3):758-64. Comment in Antimicrob Agents Ch<strong>em</strong>other. 2004;48(8):3211; authorreply 3211-2.131. Lin HC, Chu PH, Kuo YH, Shen SC. Clinical experience in managingFusarium solani keratitis. Int J Clin Pract. 2005;59(5):549-54.132. Ndoye Roth PA, Ba EA, Wane AM, De Mei<strong>de</strong>ros M, Dieng M, Ka A, etal. [Fungal keratitis in an intertropical area: diagnosis and treatmentprobl<strong>em</strong>s. Advantage of local use of polyvidone iodine]. J Fr Ophtalmol.2006;29(8):e19. French.133. Fiscella RG, Moshifar M, Messick CR, Pendland SL, Chandler JW,Viana M. Polyhexamethylene biguani<strong>de</strong> (PHMB) in the treatment ofexperimental Fusarium keratomycosis. Cornea. 1997;16(4):447-9.134. O’Day DM, Ray WA, Head WS, Robinson RD, Williams TE. Influenceof corticosteroid on experimentally induced keratomycosis. ArchOphthalmol. 1991;109(11):1601-4.135. Shi W, Wang T, Xie L, Li S, Gao H, Liu J, Li H. Risk factors, clinicalfeatures, and outcomes of recurrent fungal keratitis after corneal transplantation.Ophthalmology. 2010;117(5):890-6.Autor Correspon<strong>de</strong>nte:Guilherme Gubert MüllerAv. Des. Hugo Simas, nº 333CEP 80520-250 – Curitiba (PR), Brasile-mail: guimuller@ig.com.brRev Bras Oftalmol. 2013; 72 (2): 132-41
142 ARTIGO DE REVISÃOImportância <strong>da</strong> radiofrequência na oftalmologiaImportance of radiofrequency in ophthalmologyJosé Ricardo Carvalho Lima Reh<strong>de</strong>r 1 , Leonardo Verri Paulino 2 , Eduardo Paulino 3RESUMOEste trabalho revisa e faz uma análise crítica <strong>da</strong> radiofrequência <strong>em</strong> oftalmologia.O aquecimento <strong>da</strong> córnea t<strong>em</strong> sido realizado <strong>de</strong>s<strong>de</strong> 1889 com diferentes finali<strong>da</strong><strong>de</strong>s terapêuticas e cirúrgicas. O princípio doaquecimento <strong>da</strong> córnea causa um enrugamento do colágeno que mu<strong>da</strong> a curvatura <strong>da</strong> córnea. Após a aprovação <strong>da</strong> FDA <strong>em</strong> 2004,iniciou-se um estudo multicêntrico no Brasil coor<strong>de</strong>nado pela Facul<strong>da</strong><strong>de</strong> <strong>de</strong> Medicina do ABC que resultou na análise <strong>de</strong> 258pacientes. Como conclusão o estudo mostrou que o procedimento t<strong>em</strong> um resultado t<strong>em</strong>porário e que os melhores resultadosforam obtidos <strong>em</strong> pacientes entre 45 e 55 anos <strong>de</strong> i<strong>da</strong><strong>de</strong> s<strong>em</strong> correção óptica para longe.Acreditamos que o probl<strong>em</strong>a ain<strong>da</strong> não foi resolvido e que novas pesquisas <strong>de</strong>v<strong>em</strong> ser realiza<strong>da</strong>s.Descritores: On<strong>da</strong>s <strong>de</strong> rádio/uso terapêutico; Oftalmopatias/terapia; Topografia <strong>da</strong> córneaABSTRACTThis paper reviews and makes a critical analysis of radiofrequency in ophthalmology.Localized heating of the cornea has been apllied since 1889 for different therapeutic and surgical objectives.The principle thatheating corneal tissue causes shrinking of the collagen that changes the corneal curvature. After the approval of FDA in 2004, weinitiated a multicenter study in Brazil coordinated by ABC School of Medicine that resulted in an analyses of 258 patients. Inconclusionthe study showed that the procedure had a t<strong>em</strong>porary result and the best results were obtained in patients between 45 and 55 years oldwithout optical correction for far.We believe that the probl<strong>em</strong> has not been solved yet and a great <strong>de</strong>al of research effort should befocused.Keywords: Radio waves/therapeutic use; Eye diseases/therapy; Corneal topography1Oftalmologia <strong>da</strong> Facul<strong>da</strong><strong>de</strong> <strong>de</strong> Medicina do ABC (FMABC) – Santo André (SP), Brasil;2Oftalmologia <strong>da</strong> Facul<strong>da</strong><strong>de</strong> <strong>de</strong> Medicina do ABC (FMABC) – Santo André (SP), Brasil;3Oftalmologia <strong>da</strong> Facul<strong>da</strong><strong>de</strong> <strong>de</strong> Medicina do ABC (FMABC) – Santo André (SP), Brasil.O autor <strong>de</strong>clara não haver conflitos <strong>de</strong> interesseRecebido para publicação <strong>em</strong>: 7/10/2011 - Aceito para publicação <strong>em</strong>: 26/07/2012Rev Bras Oftalmol. 2013; 72 (2): 142-7
- Page 1 and 2:
Versão impressavol. 72 - nº 2 - M
- Page 3 and 4:
80Revista Brasileira de Oftalmologi
- Page 5 and 6:
82108 Efeitos de algumas drogas sob
- Page 7 and 8:
84Kara-Junior Ninúmeras vezes ante
- Page 9 and 10:
86Ambrósio Júnior Raplicação de
- Page 11 and 12:
88Monte FQ, Stadtherr NMINTRODUÇÃ
- Page 13 and 14: 90Monte FQ, Stadtherr NMFigura 1AFi
- Page 15 and 16: 92Monte FQ, Stadtherr NMtempo (3) .
- Page 17 and 18: 94Monte FQ, Stadtherr NM11. Höffli
- Page 19 and 20: 96Grandinetti AA, Dias J, Trautwein
- Page 21 and 22: 98Grandinetti AA, Dias J, Trautwein
- Page 23 and 24: 100Ambrósio Jr R, Ramos I, Luz A,
- Page 25 and 26: 102Ambrósio Jr R, Ramos I, Luz A,
- Page 27 and 28: 104Caballero JCS, Centurion VINTROD
- Page 29 and 30: 106Caballero JCS, Centurion VDISCUS
- Page 31 and 32: ARTIGO ORIGINALEfeitos de algumas d
- Page 33 and 34: 110Almodin J, Almodin F, Almodin E,
- Page 35 and 36: 112 ARTIGO ORIGINALFluência do las
- Page 37 and 38: 114Lucena AR, Andrade NL, Lucena DR
- Page 39 and 40: 116RELATO DE CASOAsymptomatic ocula
- Page 41 and 42: 118Freitas LGA, Gabriel LAR, Isaac
- Page 43 and 44: 120Ticly FG, Lira RPC, Fulco EAM, V
- Page 45 and 46: 122RELATO DE CASOAssociation of mac
- Page 47 and 48: 124Tavares RLP, Novelli FJ, Nóbreg
- Page 49 and 50: 126Marback EF, Freitas MS, Spínola
- Page 51 and 52: 128RELATO DE CASONeurofibromatose t
- Page 53 and 54: 130Moraes FS, Santos WEM, Salomão
- Page 55 and 56: 132 ARTIGO DE REVISÃOAntifúngicos
- Page 57 and 58: 134Müller GG, Kara-José N, Castro
- Page 59 and 60: 136Müller GG, Kara-José N, Castro
- Page 61 and 62: 138Müller GG, Kara-José N, Castro
- Page 63: 140Müller GG, Kara-José N, Castro
- Page 67 and 68: 144Rehder JRCL, Paulino LV, Paulino
- Page 69 and 70: 146Rehder JRCL, Paulino LV, Paulino
- Page 71 and 72: 148Instruções aos autoresA Revist
- Page 73: 150RevistaBrasileira deOftalmologia